Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 157

1.

TMEM97 and PGRMC1 do not mediate sigma-2 ligand-induced cell death.

Zeng C, Weng CC, Schneider ME Jr, Puentes L, Riad A, Xu K, Makvandi M, Jin L, Hawkins WG, Mach RH.

Cell Death Discov. 2019 Jan 28;5:58. doi: 10.1038/s41420-019-0141-2. eCollection 2019.

2.

Long-Term Endocrine and Exocrine Insufficiency After Pancreatectomy.

Kusakabe J, Anderson B, Liu J, Williams GA, Chapman WC, Doyle MMB, Khan AS, Sanford DE, Hammill CW, Strasberg SM, Hawkins WG, Fields RC.

J Gastrointest Surg. 2019 Jan 22. doi: 10.1007/s11605-018-04084-x. [Epub ahead of print]

PMID:
30671791
3.

Recruitment of CCR2+ tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancer.

Grossman JG, Nywening TM, Belt BA, Panni RZ, Krasnick BA, DeNardo DG, Hawkins WG, Goedegebuure SP, Linehan DC, Fields RC.

Oncoimmunology. 2018 Aug 1;7(9):e1470729. doi: 10.1080/2162402X.2018.1470729. eCollection 2018.

PMID:
30228938
4.

Residual Tumor Index: A Prognostically Significant Pathologic Parameter in Neoadjuvant-treated Pancreatic Ductal Adenocarcinoma.

Panni RZ, Gonzalez I, Hartley CP, Williams GA, Liu J, Hawkins WG, Chatterjee D.

Am J Surg Pathol. 2018 Nov;42(11):1480-1487. doi: 10.1097/PAS.0000000000001144.

PMID:
30179901
5.

Synoptic operative reporting for laparoscopic cholecystectomy and pancreaticoduodenectomy: A multi institutional pilot study evaluating completeness and surgeon perceptions.

Deal SB, D'Angelica MI, Hawkins WG, Pucci M, Ujiki M, Brunt LM, Wexner S, Alseidi AA.

Am J Surg. 2018 Nov;216(5):935-940. doi: 10.1016/j.amjsurg.2018.06.008. Epub 2018 Jun 19.

PMID:
29937324
6.

The importance of early recognition in management of ERCP-related perforations.

Bill JG, Smith Z, Brancheck J, Elsner J, Hobbs P, Lang GD, Early DS, Das K, Hollander T, Doyle MBM, Fields RC, Hawkins WG, Strasberg SM, Hammill C, Chapman WC, Edmundowicz S, Mullady DK, Kushnir VM.

Surg Endosc. 2018 May 16. doi: 10.1007/s00464-018-6235-8. [Epub ahead of print]

PMID:
29770887
7.

IL23 and TGF-ß diminish macrophage associated metastasis in pancreatic carcinoma.

Hussain SM, Reed LF, Krasnick BA, Miranda-Carboni G, Fields RC, Bi Y, Elahi A, Ajidahun A, Dickson PV, Deneve JL, Hawkins WG, Shibata D, Glazer ES.

Sci Rep. 2018 Apr 11;8(1):5808. doi: 10.1038/s41598-018-24194-5.

8.

Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance.

Meyer MA, Baer JM, Knolhoff BL, Nywening TM, Panni RZ, Su X, Weilbaecher KN, Hawkins WG, Ma C, Fields RC, Linehan DC, Challen GA, Faccio R, Aft RL, DeNardo DG.

Nat Commun. 2018 Mar 28;9(1):1250. doi: 10.1038/s41467-018-03600-6.

9.

Utility of Endoscopic Ultrasound in Evaluating Local Recurrence After Surgery for Pancreatic Cancer.

Lang GD, Mullady DK, Early DS, Hollander T, Edmundowicz SA, Murad FM, Strasberg SM, Fields RC, Hawkins WG, Doyle MB, Chapman WC, Wang-Gillam A, Kushnir VM.

Clin Gastroenterol Hepatol. 2018 Nov;16(11):1834-1835. doi: 10.1016/j.cgh.2018.02.031. Epub 2018 Mar 2.

PMID:
29505906
10.

Epidurals in Pancreatic Resection Outcomes (E-PRO) study: protocol for a randomised controlled trial.

Pak LM, Haroutounian S, Hawkins WG, Worley L, Kurtz M, Frey K, Karanikolas M, Swarm RA, Bottros MM.

BMJ Open. 2018 Jan 26;8(1):e018787. doi: 10.1136/bmjopen-2017-018787.

11.

Optimal extent of surgical and pathologic lymph node evaluation for resected intrahepatic cholangiocarcinoma.

Brauer DG, Fields RC, Tan BR Jr, Doyle MBM, Hammill CW, Hawkins WG, Colditz GA, Chapman WC.

HPB (Oxford). 2018 May;20(5):470-476. doi: 10.1016/j.hpb.2017.11.010. Epub 2018 Jan 20.

PMID:
29370972
12.

Multifunctional thiosemicarbazones and deconstructed analogues as a strategy to study the involvement of metal chelation, Sigma-2 (σ2) receptor and P-gp protein in the cytotoxic action: In vitro and in vivo activity in pancreatic tumors.

Pati ML, Niso M, Spitzer D, Berardi F, Contino M, Riganti C, Hawkins WG, Abate C.

Eur J Med Chem. 2018 Jan 20;144:359-371. doi: 10.1016/j.ejmech.2017.12.024. Epub 2017 Dec 8.

13.

Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: A multi-institution analysis from the U.S. extrahepatic biliary malignancy consortium.

Krasnick BA, Jin LX, Davidson JT 4th, Sanford DE, Ethun CG, Pawlik TM, Poultsides GA, Tran T, Idrees K, Hawkins WG, Chapman WC, Doyle MBM, Weber SM, Strasberg SM, Salem A, Martin RCG, Isom CA, Scoggins C, Schmidt CR, Shen P, Beal E, Hatzaras I, Shenoy R, Maithel SK, Fields RC.

J Surg Oncol. 2018 Mar;117(3):363-371. doi: 10.1002/jso.24836. Epub 2017 Dec 28.

14.

Adenovirus platform enhances transduction efficiency of human mesenchymal stem cells: An opportunity for cellular carriers of targeted TRAIL-based TR3 biologics in ovarian cancer.

Kuroki LM, Jin X, Dmitriev IP, Kashentseva EA, Powell MA, Mutch DG, Dietz AB, Curiel DT, Hawkins WG, Spitzer D.

PLoS One. 2017 Dec 21;12(12):e0190125. doi: 10.1371/journal.pone.0190125. eCollection 2017.

15.

Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma.

Nywening TM, Belt BA, Cullinan DR, Panni RZ, Han BJ, Sanford DE, Jacobs RC, Ye J, Patel AA, Gillanders WE, Fields RC, DeNardo DG, Hawkins WG, Goedegebuure P, Linehan DC.

Gut. 2018 Jun;67(6):1112-1123. doi: 10.1136/gutjnl-2017-313738. Epub 2017 Dec 1.

16.

Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium.

Schimizzi GV, Jin LX, Davidson JT 4th, Krasnick BA, Ethun CG, Pawlik TM, Poultsides G, Tran T, Idrees K, Isom CA, Weber SM, Salem A, Hawkins WG, Strasberg SM, Doyle MB, Chapman WC, Martin RCG, Scoggins C, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Maithel SK, Fields RC.

HPB (Oxford). 2018 Apr;20(4):332-339. doi: 10.1016/j.hpb.2017.10.003. Epub 2017 Nov 21.

PMID:
29169904
17.

Prospective Evaluation of Pasireotide in Patients Undergoing Pancreaticoduodenectomy: The Washington University Experience.

Dominguez-Rosado I, Fields RC, Woolsey CA, Williams G, Horwedel TA, Rose JB, Hammill CW, Doyle MB, Chapman WC, Strasberg SM, Hawkins WG, Sanford DE.

J Am Coll Surg. 2018 Feb;226(2):147-154.e1. doi: 10.1016/j.jamcollsurg.2017.10.021. Epub 2017 Nov 11.

PMID:
29133263
18.

Surgeon Variation in Intraoperative Supply Cost for Pancreaticoduodenectomy: Is Intraoperative Supply Cost Associated with Outcomes?

Brauer DG, Ohman KA, Jaques DP, Woolsey CA, Wu N, Liu J, Doyle MBM, Fields RC, Chapman WC, Strasberg SM, Hawkins WG.

J Am Coll Surg. 2018 Jan;226(1):37-45.e1. doi: 10.1016/j.jamcollsurg.2017.10.007. Epub 2017 Oct 19.

19.

Diagnosis and management of biliary injuries.

Rose JB, Hawkins WG.

Curr Probl Surg. 2017 Aug;54(8):406-435. doi: 10.1067/j.cpsurg.2017.06.001. Epub 2017 Jul 24. Review. No abstract available.

PMID:
28987473
20.

Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression.

Zhu Y, Herndon JM, Sojka DK, Kim KW, Knolhoff BL, Zuo C, Cullinan DR, Luo J, Bearden AR, Lavine KJ, Yokoyama WM, Hawkins WG, Fields RC, Randolph GJ, DeNardo DG.

Immunity. 2017 Sep 19;47(3):597. doi: 10.1016/j.immuni.2017.08.018. No abstract available.

Supplemental Content

Loading ...
Support Center